Figure 1
Figure 1. Phenotype of in vitro–expanded CD4+CD25+ and CD4+CD25− T-cell lines. CD4+ T cells were isolated from spleens and pooled LNs of nonmanipulated CBA mice and separated in CD25+ and CD25− subsets. (A) Representative flow cytometry histograms showing the level of surface expression of CD25, CD45RB, and CD62L on the selected cells used to generate the T-cell lines. (B) Surface expression of CD25, CD69, CD44, GITR, CD62L, CCR7, CD103, and intracellular expression of CTLA-4 was compared on the in vitro–expanded CD25− (gray line) and CD25+ line (black line) with the respective isotype controls (gray area). (C) Foxp3 mRNA was detected by RT-PCR in freshly isolated CD4+CD25− and CD4+CD25+ T cells and in the expanded CD25− and CD25+ line. The amount of β-actin mRNA was used as control. The phenotypic characterization of the T-cell lines was carried out more than 6 days after restimulation (ie, in the resting phase). Results are representative of 4 independent experiments.

Phenotype of in vitro–expanded CD4+CD25+ and CD4+CD25 T-cell lines. CD4+ T cells were isolated from spleens and pooled LNs of nonmanipulated CBA mice and separated in CD25+ and CD25 subsets. (A) Representative flow cytometry histograms showing the level of surface expression of CD25, CD45RB, and CD62L on the selected cells used to generate the T-cell lines. (B) Surface expression of CD25, CD69, CD44, GITR, CD62L, CCR7, CD103, and intracellular expression of CTLA-4 was compared on the in vitro–expanded CD25 (gray line) and CD25+ line (black line) with the respective isotype controls (gray area). (C) Foxp3 mRNA was detected by RT-PCR in freshly isolated CD4+CD25 and CD4+CD25+ T cells and in the expanded CD25 and CD25+ line. The amount of β-actin mRNA was used as control. The phenotypic characterization of the T-cell lines was carried out more than 6 days after restimulation (ie, in the resting phase). Results are representative of 4 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal